Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Biogen Inc

Recent news which mentions Biogen Inc

< Previous 1 2 3 Next >
5 things to know before the stock market opens Monday
Tags Markets Politics Lucid Group Inc
From CNBC.com News
More convenient form of breakthrough Alzheimer's drug Leqembi shows promising results in study
Tags US: News Health & Science Pharmaceuticals
From CNBC.com News
Sage Therapeutics stock plunges 48% after FDA decision on postpartum depression drug
Tags Business News Biotechnology Biotech and Pharmaceuticals
From CNBC.com News
Stocks making the biggest moves premarket: Intel, Roku, Procter & Gamble and more
Tags Chevron Corp Stock markets Earnings
From CNBC.com News
Stocks making the biggest moves midday: Spotify, RTX, General Electric and more
Tags Stock markets Earnings United Parcel Service Inc
From CNBC.com News
Biogen to cut 1,000 jobs to save costs as company prepares for Leqembi launch
Tags Business News US: News Biotechnology
From CNBC.com News
5 things to know before the stock market opens Tuesday
Tags Investment strategy Biogen Inc Business
From CNBC.com News
Eli Lilly expects FDA decision on Alzheimer's treatment donanemab by the end of the year
Tags US: News Eli Lilly and Co Health & Science
From CNBC.com News
Medicare will pay for Alzheimer's drug Leqembi. What patients and doctors should know
Tags Policy Health & Science U/S/ Economy
From CNBC.com News
Sales of Alzheimer’s drug Leqembi may be slow initially but could pick up in 2024
Tags Biotechnology Alzheimer's disease Biotech and Pharmaceuticals
From CNBC.com News
Stocks making the biggest moves midday: Rivian, Levi Strauss, Biogen, First Solar and more
Tags First Solar Inc Stock markets Levi Strauss & Co
From CNBC.com News
Stocks making the biggest premarket moves: Levi Strauss, Biogen, Alibaba and more
Tags stocks Costco Wholesale Corp Markets
From CNBC.com News
Japanese pharma Eisai slides 4% despite FDA approval for Alzheimer's drug
Tags Science Eisai Co Ltd Biotech and Pharmaceuticals
From CNBC.com News
FDA approves Alzheimer’s drug Leqembi, paving way for broader Medicare coverage
Tags US: News Social issues Policy
From CNBC.com News
Stocks making the biggest moves midday: JD.Com, Biogen, Oracle and more
Tags Breaking News: Markets JD/Com Inc Economy
From CNBC.com News
FDA advisors to weigh whether Alzheimer's drug Leqembi should receive full approval
Tags Breaking News: Business Science Business News
From CNBC.com News
Bernie Sanders says price of Alzheimer's treatment is unconscionable, calls on HHS to take action
Tags Business Biogen Inc Health care industry
From CNBC.com News
Jim Cramer expects defensive stocks to be resilient as debt ceiling talks drag on
Tags Pharmaceuticals stocks Markets
From CNBC.com News
Alzheimer's treatment Leqembi could cost Medicare up to $5 billion per year, study estimates
Tags US: News Eli Lilly and Co Health & Science
From CNBC.com News
Stocks making the biggest moves premarket: Starbucks, AMD, Pearson, PacWest & more
Tags Starbucks Corp Western Alliance Bancorp Biogen Inc
From CNBC.com News
Bipartisan attorneys general call on Medicare to cover Alzheimer's treatments
Tags US Economy US: News US Top News and Analysis
From CNBC.com News
Alzheimer’s patients may wait years to get treated with new drugs, putting them at risk of more severe disease
Tags Quanterix Corp Politics U/S/ Economy
From CNBC.com News
Alzheimer's: Medicare will cover Leqembi for all patients if FDA approves drug, CMS chief says
Tags Biotech and Pharmaceuticals Biotechnology Epidemics
From CNBC.com News
Biogen isn't concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says
Tags Breaking news Companies Business
From CNBC.com News
FDA grants accelerated approval for Biogen ALS drug that treats rare form of the disease
Tags Biotech and Pharmaceuticals Biotechnology Science
From CNBC.com News
Alzheimer’s patients retain the benefits of Leqembi even when they stop the drug, Eisai says
Tags US: News Eli Lilly and Co Pharmaceuticals
From CNBC.com News
Eli Lilly says experimental Alzheimer's drug reduces brain plaque in early study
Tags Health & Science Pharmaceuticals Eli Lilly and Co
From CNBC.com News
FDA advisors reject Biogen's ALS drug for rare and aggressive form of the disease
Tags Breaking news Health care industry Health & Science
From CNBC.com News
FDA staff says Biogen's ALS drug may have a 'clinical benefit' on a rare form of the disease
Tags Health & Science Pharmaceuticals US: News
From CNBC.com News
Veterans' Health will cover Alzheimer's treatment Leqembi for some patients
Tags Health & Science Policy Disease outbreaks
From CNBC.com News
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.